NEWS

WIRES

OTHER

ChromaGen Unveils Treatment for Symptoms of Visual Learning Disorders and Color Blindness

"We have been overwhelmed by the response from the first recipients of ChromaGen lenses, who are reporting dramatic, instantaneous relief from conditions that were previously debilitating," said Ted Edwards Jr., CEO of ChromaGen. "This technology stands to be truly life-changing for those who suffer with visual reading disorders often associated with dyslexia or who live with color blindness."

Cleared by the U.S. Food and Drug Administration (FDA), the ChromaGen technology can be prescribed as a colored filter to aid individuals who experience reading discomfort and can be prescribed to enhance color discrimination in patients with color vision deficiencies.

ChromaGen works by re-synchronizing and selectively changing the wavelength of light entering the eyes, which is the cause of many of the symptoms associated with visual reading disorders and color blindness. The technology can help people of all ages who are suffering from the following symptoms:

• Double vision
• Blurry, irregular or moving text when reading
• Loss of focus when reading
• Shifting words or letters, or moving spacing between lines when reading
• Color blindness or color deficiency

Research has shown that approximately one out of two people with dyslexia and 97 percent of those with color blindness can experience instant relief with ChromaGen lenses.

"When a patient is tested by their eye doctor for ChromaGen lenses, they will know immediately if the lenses can help them," said Dr. Michael Politzer, a ChromaGen Practitioner. "The most poignant cases we have seen are children who struggled with reading, but with the right ChromaGen prescription, have been able to read like never before. The ability to read without words moving on the page or coming in and out of focus gives these kids hope and confidence to pursue dreams they thought might have been out of reach."

Available only by prescription, the ChromaGen system consists of 16 subtly shaded lenses. An optometrist or ophthalmologist specially trained to test a patient to determine if he or she is a viable candidate for ChromaGen technology tests each eye separately to find the best combination of lenses. Every prescription is tailored to the individual. A ChromaGen prescription can be incorporated into an existing prescription for eyeglasses or contact lenses.

Individuals can determine if ChromaGen lenses might be right for them or their child by completing a simple seven-question survey on the ChromaGen website: http://chromagenvisionllc.com/home/chromagen-7-question-survey/. To locate a ChromaGen-certified doctor to perform an in-office exam, or to more learn more about ChromaGen, visit www.chromagenvisionllc.com.

ChromaGen has patent protection that runs through 2028 on a patent titled, "Tinted Lens and Method of Making the Same." The patent is further described as an ophthalmic lens used to correct color blindness or dyslexia in a wearer.

About ChromaGen

ChromaGen is a life changing aid for visual reading disorders often associated with dyslexia and an optical corrective solution for color deficiency (more commonly known as color blindness). ChromaGen provides dramatic results immediately with no side effects or invasive procedures. The lenses can be incorporated into any existing prescription. ChromaGen has been cleared by the U.S. Food and Drug Administration (FDA) and has patent protection that runs through 2028. For more information about ChromaGen, please visit http://www.ChromaGenVisionllc.com.

Seigenthaler Public Relations
Nicole Cottrill or Amy Hall, 615-327-7999
ncottrill@seigenthaler.com
ahall@seigenthaler.com